{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T20:59:51Z","timestamp":1743022791804,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493933884"},{"type":"electronic","value":"9781493933891"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3389-1_35","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:22:46Z","timestamp":1460632966000},"page":"529-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines"],"prefix":"10.1007","author":[{"given":"Thomas H.","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Hermreck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Bellgrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Rodell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"35_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/87974","volume":"7","author":"A Stubbs","year":"2001","unstructured":"Stubbs A, Martin KS, Coeshott C et al (2001) Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med 7:625\u2013629","journal-title":"Nat Med"},{"key":"35_CR2","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1016\/j.vaccine.2011.04.101","volume":"29","author":"V Cereda","year":"2011","unstructured":"Cereda V, Vergati M, Huen N-Y et al (2011) Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells. Vaccine 29:4992\u20134999","journal-title":"Vaccine"},{"key":"35_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1189\/jlb.1210702","volume":"90","author":"S-C Cheng","year":"2011","unstructured":"Cheng S-C, van de Veerdonk FL, Lenardon M et al (2011) The dectin-1\/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol 90:357\u2013366","journal-title":"J Leukoc Biol"},{"key":"35_CR4","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1016\/j.vaccine.2014.07.027","volume":"32","author":"A Gaggar","year":"2014","unstructured":"Gaggar A, Coeshott C, Apelian D et al (2014) Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study. Vaccine 32:4925\u20134931","journal-title":"Vaccine"},{"key":"35_CR5","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1158\/1078-0432.CCR-08-0393","volume":"14","author":"EK Wansley","year":"2008","unstructured":"Wansley EK, Chakraborty M, Hance KW et al (2008) Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res 14:4316\u20134325","journal-title":"Clin Cancer Res"},{"key":"35_CR6","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1158\/1078-0432.CCR-13-1026","volume":"19","author":"A Ardiani","year":"2013","unstructured":"Ardiani A, Farsaci B, Rogers CJ et al (2013) Combination therapy with a second-generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer model. Clin Cancer Res 19:6205\u20136218","journal-title":"Clin Cancer Res"},{"key":"35_CR7","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1158\/0008-5472.CAN-13-2045","volume":"74","author":"A Ardiani","year":"2014","unstructured":"Ardiani A, Gameiro SR, Palena C et al (2014) Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process. Cancer Res 74:1945\u20131957","journal-title":"Cancer Res"},{"issue":"7","key":"35_CR8","doi-asserted-by":"publisher","first-page":"e101904","DOI":"10.1371\/journal.pone.0101904","volume":"9","author":"TH King","year":"2014","unstructured":"King TH, Kemmler CB, Guo Z et al (2014) A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS One 9(7):e101904","journal-title":"PLoS One"},{"key":"35_CR9","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.vaccine.2006.10.035","volume":"25","author":"A Haller","year":"2007","unstructured":"Haller A, Lauer GM, King TH et al (2007) Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine 25:1452\u20131463","journal-title":"Vaccine"},{"key":"35_CR10","first-page":"321","volume":"34","author":"H Wu","year":"2014","unstructured":"Wu H, Ng BSH, Thibault G (2014) Endoplasmic reticulum stress response in yeast and humans. Biosci Rep 34:321\u2013330","journal-title":"Biosci Rep"},{"key":"35_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/yea.2930","volume":"29","author":"MWY Shen","year":"2012","unstructured":"Shen MWY, Fang F, Sandmeyer S et al (2012) Development and characterization of a vector set with regulated promoters for systematic metabolic engineering in Saccharomyces cerevisiae. Yeast 29:495\u2013503","journal-title":"Yeast"},{"key":"35_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/nar\/gkm1102","volume":"36","author":"S Nakagawa","year":"2008","unstructured":"Nakagawa S, Niimura Y, Gojobori T et al (2008) Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes. Nucleic Acids Res 36:861\u2013871","journal-title":"Nucleic Acids Res"},{"key":"35_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0003-2697(73)90217-0","volume":"56","author":"W Schaffner","year":"1973","unstructured":"Schaffner W, Weissmann C (1973) A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem 56:502\u2013514","journal-title":"Anal Biochem"},{"key":"35_CR14","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.18632\/oncotarget.1295","volume":"4","author":"DH Hamilton","year":"2013","unstructured":"Hamilton DH, Litzinger MT, Jales A et al (2013) Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine. Oncotarget 4:1777\u20131790","journal-title":"Oncotarget"},{"key":"35_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","volume":"281","author":"MR Betts","year":"2003","unstructured":"Betts MR, Brenchley JM, Price DA et al (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281:65\u201378","journal-title":"J Immunol Methods"},{"key":"35_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ymthe.2004.05.035","volume":"10","author":"HA Andersson","year":"2004","unstructured":"Andersson HA, Barry MA (2004) Maximizing antigen targeting to the proteasome for gene-based vaccines. Mol Ther 10:432\u2013446","journal-title":"Mol Ther"},{"key":"35_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/jid.2011.346","volume":"132","author":"C Liard","year":"2011","unstructured":"Liard C, Munier S, Joulin-Giet A et al (2011) Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses. J Invest Dermatol 132:615\u2013625","journal-title":"J Invest Dermatol"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3389-1_35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T10:05:33Z","timestamp":1608631533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3389-1_35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933884","9781493933891"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3389-1_35","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"14 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}